Catalysts
Catalysts
The next six months hinge on Q4 FY26 results (expected late May 2026) — the single quarter that validates or breaks management's 60% revenue growth guidance and, more importantly, reveals whether the ₹1,355 Cr cumulative DTA tailwind has exhausted, forcing consensus to reprice from ₹2,000+ Cr headline PAT to ₹1,100–1,400 Cr normalized earnings. The calendar beyond Q4 is moderately loaded: Q1 FY27 results (August 2026), the first Blue Sky European order announcement (H2 CY2026), and AGM (August–September 2026). But only the earnings normalization and receivables trajectory can change underwriting. Everything else is narrative.
Hard-Dated Events (6 months)
High-Impact Catalysts
Next Hard Date (days)
Signal Quality (1–5)
Decision point: Q4 FY26 results (expected late May 2026). Management needs roughly ₹6,200 Cr in revenue and 855 MW in deliveries to meet 60% growth guidance — when the best-ever quarter was 617 MW. Analyst PAT estimate: ₹540–600 Cr. The market will mark the stock on three items: whether receivables stabilize, whether WTG EBITDA margin holds above 16%, and whether Q4 PAT drops sharply as DTA recognition ends. A miss on all three triggers a sell-side estimate reset from the ₹2,072 Cr FY25 anchor to ₹1,100–1,400 Cr normalized earnings — compressing the effective P/E from the advertised 24x to 49–72x.
Ranked Catalyst Timeline
Impact Matrix
Next 90 Days
Binder Error: Set operations can only apply to expressions with the same number of result columns
The 90-day calendar is dominated by one event: Q4 FY26 results. If the company delivers on 60% growth and WTG margin holds, the stock's April 2026 rally gets validated by fundamentals. If it misses — particularly on receivables or cash conversion — the rally is a short-covering squeeze into an earnings downgrade cycle. There are no other material hard-dated catalysts inside 90 days. The calendar beyond Q4 is moderately loaded (Q1 FY27, AGM, Blue Sky orders) but none of those events are as binary.
What Would Change the View
Three observable signals would most shift the investment debate over the next six months. First, two consecutive quarters of CFO exceeding reported net income with DSO declining below 110 — this is the bear's cover signal and would prove that the 0.30x three-year cash conversion was a temporary scaling artifact rather than a structural quality defect; if it happens alongside the DTA exhaustion, the market would reprice the company on operating cash flow rather than headline earnings, which is a far more durable multiple. Second, book-to-bill falling below 1.0x for two consecutive quarters — this is the bull's disconfirming signal and would indicate the domestic wind cycle is rolling over before Suzlon has fully converted its 6.4 GW backlog; the last time this happened (FY17–FY18), revenue subsequently fell 85% peak-to-trough. Third, a signed Blue Sky order from a European customer — this would transform the variant perception that Suzlon is a domestic-only cyclical into a global-platform story, and would be the first time in a decade that Suzlon had a credible international revenue pipeline funded from strength rather than leverage. The Blue Sky signal is lower probability but higher narrative impact; the cash conversion and book-to-bill signals are the ones that change sizing.